MedPath

An evaluation and an examination of the cancer immunology for resectable non-small cell lung cancer

Not Applicable
Conditions
Patients with resectable non-small cell lung cancer who are going to receive pulmonary resection
Registration Number
JPRN-UMIN000031128
Lead Sponsor
Tohoku Medical and Pharmaceutical University, Tohoku Medical and Pharmaceutical University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients having an overlap cancer with activity Patients that an doctor judged to be inappropriate

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We study the immune charge of cancer, immune cells, and the neighborhood of cancer microenvironment by pneumonectomy for patients with resecrable non-small-cell lung cancer, and clinical outcome.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath